BRAF and melanoma: Since the MAPK pathway is frequently activated in melanoma via mutation of BRAF or NRAS and p300 acetyl transferase activity is enhanced by MAPK-mediated phosphorylation in keratinocytes (Chen et al., 2007), we asked whether MAPK signaling activates acetylation in melanoma.